ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma (APROMISS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03016819
Recruitment Status : Recruiting
First Posted : January 11, 2017
Last Update Posted : March 19, 2018
Sponsor:
Information provided by (Responsible Party):
Advenchen Laboratories, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : April 2021
  Estimated Study Completion Date : August 2021